Ondansetron in multiple sclerosis

J Pain Symptom Manage. 2000 Nov;20(5):388-91. doi: 10.1016/s0885-3924(00)00205-0.

Abstract

Two young women with chronic nausea and vertigo caused by multiple sclerosis responded to the introduction and maintenance of the 5HT3 receptor antagonist, ondansetron. Palliative care is a neglected aspect of management of degenerative neurological diseases and these cases highlight the approaches that may be used to manage difficult symptoms in the population with multiple sclerosis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Multiple Sclerosis / complications*
  • Nausea / drug therapy*
  • Nausea / etiology*
  • Ondansetron / therapeutic use*
  • Palliative Care
  • Serotonin Antagonists / therapeutic use*
  • Treatment Outcome
  • Vertigo / drug therapy*
  • Vertigo / etiology*

Substances

  • Serotonin Antagonists
  • Ondansetron